$EPC

Edgewell reported Q4 2026 net sales of $484.1M, up 3.0%, and adjusted EPS of $0.78. Full-year sales rose 1.8% to $1.997B, with adjusted EPS at $1.93. The company forecasted fiscal 2027 adjusted EPS of $1.85 to $2.15. Growth was driven by North America and International markets, with notable gains in Grooming and Sun and Skin Care segments.

Edgewell Personal Care, maker of Schick and other brands, will report fiscal 2026 results on Nov. 12. A live webcast and replay will be available on the company's website. Edgewell operates in over 50 markets with a portfolio of personal care products.

Elf Beauty (ELF) shares rose after Canaccord's sales tracker showed 11.6% year-over-year dollar sales growth, with Naturium brand up 74.3%. Edgewell (EPC) saw 3.0% sales growth, driven by Edge and Cremo shave products. Perrigo (PRGO) reported 9.3% year-over-year growth in private label infant formula sales.

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 17, 2026, Edgewell Personal Care Company (the “Company”) determined that LaTanya Langley will serve as the Com

Edgewell Personal Care (EPC) reported Q3 2026 results with net sales up 1.7% to $570.1M, driven by North America's 3.0% organic growth. However, operating income fell 44% due to margin declines and higher costs. Adjusted EPS held at $0.72, matching prior year. CEO Rod Little called it an 'important step forward.'

Colgate-Palmolive (CL) is exploring the sale of Softsoap, Irish Spring, and Speed Stick, with Goldman Sachs advising. North America revenue fell 3% in Q2 2026, and the company aims to fund premium innovation. Shares were at $87.49 in premarket trading on September 14, 2026, down 3.7% over one week but up 9.9% year to date. Potential buyers include private equity firms, with strategic acquirers facing scale or leverage limitations.

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.

Edgewell Personal Care reported Q2 revenue of $570.1M versus $577.1M expected, with adjusted EPS of $0.72 versus $0.61 and adjusted EBITDA of $71.6M versus $72.89M. Full-year adjusted EPS guidance is $1.90 (midpoint) and EBITDA guidance $255M. Margin fell to 4.4% from 8% as brand spending rose and Wet Shave manufacturing consolidation disrupted supply.